adenosine has been researched along with Neutropenia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butcher, SE; Cui, Q; Montemayor, EJ; Nomura, Y; Roston, D | 1 |
| Belalcazar-Portacio, A; Keough, LA; Ramanathan, KB; Shah, R | 1 |
| Marsh, JD; Vander Heide, RS | 1 |
| Forman, MB; Puett, DW; Virmani, R | 1 |
1 review(s) available for adenosine and Neutropenia
| Article | Year |
|---|---|
Mechanisms and therapy of myocardial reperfusion injury.
Topics: Adenosine; Animals; Antioxidants; Biomechanical Phenomena; Blood Substitutes; Coronary Circulation; Endothelium, Vascular; Fluorocarbons; Free Radicals; Myocardial Reperfusion; Myocardial Reperfusion Injury; Neutropenia; Neutrophils; Oxygen | 1990 |
3 other study(ies) available for adenosine and Neutropenia
| Article | Year |
|---|---|
Structural and mechanistic basis for preferential deadenylation of U6 snRNA by Usb1.
Topics: Adenosine; Adenosine Monophosphate; Base Sequence; Crystallography, X-Ray; Genetic Predisposition to Disease; Humans; Models, Molecular; Mutation; Neutropenia; Nucleic Acid Conformation; Phosphoric Diester Hydrolases; Protein Binding; Protein Conformation; RNA, Small Nuclear; Skin Abnormalities; Substrate Specificity; Uridine | 2018 |
Ticagrelor as an alternative in clopidogrel-associated neutropenia.
Topics: Acute Coronary Syndrome; Adenosine; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Drug Substitution; Humans; Male; Neutropenia; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine; Treatment Outcome | 2015 |
Through the looking glass: a positive inotropic drug and ischemic preconditioning.
Topics: 5'-Nucleotidase; Adenosine; Animals; Cardiotonic Agents; Dogs; Drug Approval; Enzyme Activation; Heart Failure; Humans; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardium; Neutropenia; Protein Kinase C; Pyrazines; Quinolines; Second Messenger Systems | 1997 |